Zentalis Pharmaceuticals ...

NASDAQ: ZNTL · Real-Time Price · USD
1.59
0.11 (7.43%)
At close: Aug 15, 2025, 3:59 PM
1.56
-2.19%
After-hours: Aug 15, 2025, 07:25 PM EDT

Zentalis Pharmaceuticals Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Net Income
-26.87M -48.28M -47.47M -40.19M -88.28M 10.07M -60.92M -55.54M -112.56M -63.26M -54.98M -54.5M -68.39M -59.24M -50.09M -10.49M -55.06M -50.44M
Depreciation & Amortization
160K 262K 317K 321K 327K 324K 337K 348K 344K 360K 359K 375K 348K 344K 209K 137K 119K 79K
Stock-Based Compensation
6.29M 6.49M 31.36M 10.36M 12.71M 12.83M 13.88M 13.87M 13.34M 13.73M 9.61M 10.32M 16.76M 10.15M 8.47M 7.66M 9.92M 9.69M
Other Working Capital
2.26M 777K 486K 4.75M 2.3M -1.06M -129K -1.55M -770K -2.61M -12.11M 3.17M -1.61M -2.77M 1.47M -392K -515K 782K
Other Non-Cash Items
-5.95M 7.14M -16.83M -16.75M 26M -58.89M -10K -2.12M 25.52M 4M 4.47M 1.1M 5.19M 1.97M 1.99M -49.7M -256K -239K
Deferred Income Tax
n/a n/a n/a n/a n/a n/a -4.16M n/a -756K -97K -769K -125K 74K -74K 36K 6.3M 488K 543K
Change in Working Capital
-8.33M 1.75M -7.08M 2.21M 14.1M -16.3M 10.27M 4.78M -5.16M -4.02M 3.98M 9.63M 2.99M -3.35M 2.37M 12.61M -1.32M 2.9M
Operating Cash Flow
-34.71M -32.64M -39.7M -44.05M -35.14M -51.97M -40.6M -38.66M -79.28M -49.28M -37.33M -33.2M -43.03M -50.2M -37.02M -33.49M -46.11M -37.47M
Capital Expenditures
n/a n/a n/a n/a -181K -40K -173K -91K -319K n/a -160K -1.66M -278K -450K -2.19M -2.66M -819K -436K
Cash Acquisitions
564K 5K n/a -65K 65K n/a 41.89K 117.36K -73.25K n/a 11.73K -21.68K 141.82K n/a n/a -14.32M n/a n/a
Purchase of Investments
-40.19M -19.53M -39.22M -59.24M -19.39M -10.12M -95.99M -264.11M -125.21M -63.88M -125.98M -129.6M -198.32M -79.25M -83.22M -202.47M -23.38M -54.43M
Sales Maturities Of Investments
70M 60M 71.5M 107.48M 54M 71.7M 54.1M 146.75M 198.46M 106M 114.25M 151.28M 56.5M 99.5M 128.68M 78.01M 90.8M 68.33M
Other Investing Acitivies
n/a n/a n/a 65K n/a n/a -41.89K -117.36K 73.25K 42.12K -11.73K 21.68K -141.82K 20.25M 45.46M -14.32M 67.42M 13.89M
Investing Cash Flow
30.38M 40.48M 32.28M 48.24M 34.49M 61.55M -42.06M -117.45M 72.93M 42.12M -11.89M 20.02M -142.1M 19.8M 43.27M -141.44M 66.6M 13.46M
Debt Repayment
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Common Stock Repurchased
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Financial Acitivies
n/a n/a 349K n/a n/a -241K n/a n/a n/a n/a n/a n/a n/a n/a -1.15M 386K -386K n/a
Financial Cash Flow
n/a 189K n/a 92K 9K 7K n/a 309K 236.62M 373K 49.74M 589K 209.46M 1.26M 12.27M 166.57M -316K n/a
Net Cash Flow
-4.33M 8.03M -7.42M 4.29M -640K 9.58M -82.71M -155.81M 230.28M -6.79M 518K -12.59M 24.33M -29.14M 18.51M -8.36M 20.17M -24.01M
Free Cash Flow
-34.71M -32.64M -39.7M -44.05M -35.32M -52.01M -40.77M -38.76M -79.59M -49.28M -37.49M -34.86M -43.3M -50.65M -39.21M -36.15M -46.93M -37.91M